nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLCO1A2—Chlorambucil—testicular cancer	0.0813	0.103	CbGbCtD
Glyburide—ABCC1—Dactinomycin—testicular cancer	0.0438	0.0555	CbGbCtD
Glyburide—ABCC3—Cisplatin—testicular cancer	0.0409	0.0519	CbGbCtD
Glyburide—ABCC3—Etoposide—testicular cancer	0.0402	0.051	CbGbCtD
Glyburide—ABCB11—Vinblastine—testicular cancer	0.0386	0.049	CbGbCtD
Glyburide—CFTR—vas deferens—testicular cancer	0.0334	0.382	CbGeAlD
Glyburide—ABCC1—Epirubicin—testicular cancer	0.0317	0.0402	CbGbCtD
Glyburide—ABCG2—Dactinomycin—testicular cancer	0.0293	0.0372	CbGbCtD
Glyburide—ABCC3—Doxorubicin—testicular cancer	0.0274	0.0348	CbGbCtD
Glyburide—ABCC1—Vinblastine—testicular cancer	0.0274	0.0348	CbGbCtD
Glyburide—ABCC3—Methotrexate—testicular cancer	0.0266	0.0337	CbGbCtD
Glyburide—ABCC1—Etoposide—testicular cancer	0.0247	0.0313	CbGbCtD
Glyburide—ABCB11—Doxorubicin—testicular cancer	0.0237	0.0301	CbGbCtD
Glyburide—ABCC2—Carboplatin—testicular cancer	0.0218	0.0276	CbGbCtD
Glyburide—SLC22A7—Methotrexate—testicular cancer	0.0208	0.0264	CbGbCtD
Glyburide—ABCC2—Vinblastine—testicular cancer	0.0203	0.0257	CbGbCtD
Glyburide—ABCG2—Carboplatin—testicular cancer	0.0197	0.025	CbGbCtD
Glyburide—ABCC2—Cisplatin—testicular cancer	0.0186	0.0236	CbGbCtD
Glyburide—ABCC2—Etoposide—testicular cancer	0.0183	0.0232	CbGbCtD
Glyburide—ABCC1—Doxorubicin—testicular cancer	0.0168	0.0214	CbGbCtD
Glyburide—ABCG2—Cisplatin—testicular cancer	0.0168	0.0213	CbGbCtD
Glyburide—ABCG2—Etoposide—testicular cancer	0.0165	0.021	CbGbCtD
Glyburide—ABCC1—Methotrexate—testicular cancer	0.0163	0.0207	CbGbCtD
Glyburide—CYP2C19—Ifosfamide—testicular cancer	0.0155	0.0196	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—testicular cancer	0.0146	0.0185	CbGbCtD
Glyburide—CYP2C9—Ifosfamide—testicular cancer	0.0128	0.0163	CbGbCtD
Glyburide—ABCC2—Doxorubicin—testicular cancer	0.0125	0.0158	CbGbCtD
Glyburide—ABCC2—Methotrexate—testicular cancer	0.0121	0.0153	CbGbCtD
Glyburide—CFTR—semen—testicular cancer	0.0119	0.136	CbGeAlD
Glyburide—ABCG2—Doxorubicin—testicular cancer	0.0113	0.0143	CbGbCtD
Glyburide—ABCG2—Methotrexate—testicular cancer	0.0109	0.0139	CbGbCtD
Glyburide—ABCB1—Dactinomycin—testicular cancer	0.0106	0.0134	CbGbCtD
Glyburide—SLC22A6—Methotrexate—testicular cancer	0.00884	0.0112	CbGbCtD
Glyburide—ALB—Methotrexate—testicular cancer	0.00753	0.00955	CbGbCtD
Glyburide—CYP3A4—Ifosfamide—testicular cancer	0.00747	0.00948	CbGbCtD
Glyburide—ABCB1—Vinblastine—testicular cancer	0.00661	0.00839	CbGbCtD
Glyburide—CYP2C9—Cisplatin—testicular cancer	0.00625	0.00793	CbGbCtD
Glyburide—ABCB1—Cisplatin—testicular cancer	0.00606	0.00769	CbGbCtD
Glyburide—ABCB1—Etoposide—testicular cancer	0.00596	0.00756	CbGbCtD
Glyburide—ABCB1—Doxorubicin—testicular cancer	0.00406	0.00516	CbGbCtD
Glyburide—CYP3A4—Vinblastine—testicular cancer	0.00396	0.00503	CbGbCtD
Glyburide—ABCB1—Methotrexate—testicular cancer	0.00394	0.00499	CbGbCtD
Glyburide—CYP3A4—Etoposide—testicular cancer	0.00357	0.00453	CbGbCtD
Glyburide—CFTR—seminal vesicle—testicular cancer	0.00252	0.0289	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—testicular cancer	0.00243	0.00309	CbGbCtD
Glyburide—ABCC9—female gonad—testicular cancer	0.00231	0.0265	CbGeAlD
Glyburide—CPT1A—gonad—testicular cancer	0.00207	0.0237	CbGeAlD
Glyburide—ABCC9—testis—testicular cancer	0.00205	0.0235	CbGeAlD
Glyburide—CPT1A—female gonad—testicular cancer	0.00168	0.0193	CbGeAlD
Glyburide—ABCC8—seminal vesicle—testicular cancer	0.00157	0.018	CbGeAlD
Glyburide—ABCA1—female gonad—testicular cancer	0.00157	0.018	CbGeAlD
Glyburide—CPT1A—testis—testicular cancer	0.00149	0.0171	CbGeAlD
Glyburide—ABCC9—lymph node—testicular cancer	0.00149	0.017	CbGeAlD
Glyburide—CFTR—female gonad—testicular cancer	0.00148	0.017	CbGeAlD
Glyburide—ABCA1—testis—testicular cancer	0.00139	0.0159	CbGeAlD
Glyburide—CFTR—testis—testicular cancer	0.00131	0.015	CbGeAlD
Glyburide—CPT1A—lymph node—testicular cancer	0.00108	0.0124	CbGeAlD
Glyburide—ABCB11—testis—testicular cancer	0.00108	0.0123	CbGeAlD
Glyburide—ABCA1—lymph node—testicular cancer	0.00101	0.0115	CbGeAlD
Glyburide—KCNJ11—female gonad—testicular cancer	0.001	0.0115	CbGeAlD
Glyburide—SLC22A7—testis—testicular cancer	0.000972	0.0111	CbGeAlD
Glyburide—SLC15A2—seminal vesicle—testicular cancer	0.000938	0.0107	CbGeAlD
Glyburide—ABCC1—seminal vesicle—testicular cancer	0.000927	0.0106	CbGeAlD
Glyburide—ABCC8—testis—testicular cancer	0.000817	0.00935	CbGeAlD
Glyburide—ABCC3—female gonad—testicular cancer	0.000774	0.00886	CbGeAlD
Glyburide—ABCG2—seminal vesicle—testicular cancer	0.000768	0.00879	CbGeAlD
Glyburide—SLCO2B1—female gonad—testicular cancer	0.000721	0.00826	CbGeAlD
Glyburide—ABCC3—testis—testicular cancer	0.000686	0.00786	CbGeAlD
Glyburide—KCNJ11—lymph node—testicular cancer	0.000643	0.00736	CbGeAlD
Glyburide—SLCO2B1—testis—testicular cancer	0.00064	0.00732	CbGeAlD
Glyburide—SLCO1A2—testis—testicular cancer	0.000589	0.00674	CbGeAlD
Glyburide—ALB—testis—testicular cancer	0.000585	0.0067	CbGeAlD
Glyburide—SLC15A2—female gonad—testicular cancer	0.000551	0.0063	CbGeAlD
Glyburide—ABCC2—testis—testicular cancer	0.000548	0.00628	CbGeAlD
Glyburide—ABCC1—female gonad—testicular cancer	0.000544	0.00623	CbGeAlD
Glyburide—ABCC3—lymph node—testicular cancer	0.000497	0.00569	CbGeAlD
Glyburide—SLC15A2—testis—testicular cancer	0.000488	0.00559	CbGeAlD
Glyburide—ABCC1—testis—testicular cancer	0.000483	0.00553	CbGeAlD
Glyburide—SLCO2B1—lymph node—testicular cancer	0.000464	0.00531	CbGeAlD
Glyburide—ABCG2—female gonad—testicular cancer	0.000451	0.00516	CbGeAlD
Glyburide—ALB—lymph node—testicular cancer	0.000424	0.00486	CbGeAlD
Glyburide—ABCB1—embryo—testicular cancer	0.000403	0.00461	CbGeAlD
Glyburide—ABCG2—testis—testicular cancer	0.0004	0.00458	CbGeAlD
Glyburide—ABCC2—lymph node—testicular cancer	0.000397	0.00455	CbGeAlD
Glyburide—ABCB1—seminal vesicle—testicular cancer	0.000379	0.00433	CbGeAlD
Glyburide—SLC15A2—lymph node—testicular cancer	0.000354	0.00405	CbGeAlD
Glyburide—ABCC1—lymph node—testicular cancer	0.00035	0.00401	CbGeAlD
Glyburide—ABCG2—lymph node—testicular cancer	0.00029	0.00332	CbGeAlD
Glyburide—ABCB1—gonad—testicular cancer	0.000274	0.00313	CbGeAlD
Glyburide—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000257	0.00207	CcSEcCtD
Glyburide—Asthenia—Vinblastine—testicular cancer	0.000257	0.00207	CcSEcCtD
Glyburide—Tremor—Cisplatin—testicular cancer	0.000256	0.00206	CcSEcCtD
Glyburide—Alopecia—Etoposide—testicular cancer	0.000254	0.00204	CcSEcCtD
Glyburide—Nervous system disorder—Ifosfamide—testicular cancer	0.000254	0.00204	CcSEcCtD
Glyburide—Thrombocytopenia—Ifosfamide—testicular cancer	0.000253	0.00203	CcSEcCtD
Glyburide—Anaemia—Cisplatin—testicular cancer	0.000252	0.00203	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—testicular cancer	0.000252	0.00203	CcSEcCtD
Glyburide—Hyperhidrosis—Ifosfamide—testicular cancer	0.00025	0.00201	CcSEcCtD
Glyburide—Feeling abnormal—Bleomycin—testicular cancer	0.000249	0.002	CcSEcCtD
Glyburide—Vomiting—Chlorambucil—testicular cancer	0.000249	0.002	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000247	0.00198	CcSEcCtD
Glyburide—Anorexia—Ifosfamide—testicular cancer	0.000247	0.00198	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—testicular cancer	0.000245	0.00197	CcSEcCtD
Glyburide—Diarrhoea—Vinblastine—testicular cancer	0.000245	0.00197	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—testicular cancer	0.000245	0.00197	CcSEcCtD
Glyburide—Leukopenia—Cisplatin—testicular cancer	0.000245	0.00196	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—testicular cancer	0.000244	0.00196	CcSEcCtD
Glyburide—Purpura—Epirubicin—testicular cancer	0.000242	0.00194	CcSEcCtD
Glyburide—Hypotension—Ifosfamide—testicular cancer	0.000242	0.00194	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—testicular cancer	0.000241	0.00194	CcSEcCtD
Glyburide—Urticaria—Bleomycin—testicular cancer	0.00024	0.00193	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—testicular cancer	0.00024	0.00193	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—testicular cancer	0.000239	0.00192	CcSEcCtD
Glyburide—Convulsion—Cisplatin—testicular cancer	0.000237	0.0019	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000236	0.00189	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—testicular cancer	0.000234	0.00188	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—testicular cancer	0.000233	0.00188	CcSEcCtD
Glyburide—Diplopia—Epirubicin—testicular cancer	0.000233	0.00187	CcSEcCtD
Glyburide—Myalgia—Cisplatin—testicular cancer	0.000233	0.00187	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—testicular cancer	0.000233	0.00187	CcSEcCtD
Glyburide—Nausea—Chlorambucil—testicular cancer	0.000232	0.00187	CcSEcCtD
Glyburide—Paraesthesia—Ifosfamide—testicular cancer	0.000232	0.00187	CcSEcCtD
Glyburide—Anaemia—Etoposide—testicular cancer	0.000231	0.00186	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000231	0.00185	CcSEcCtD
Glyburide—Dyspnoea—Ifosfamide—testicular cancer	0.000231	0.00185	CcSEcCtD
Glyburide—Vomiting—Vinblastine—testicular cancer	0.000228	0.00183	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—testicular cancer	0.000226	0.00182	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—testicular cancer	0.000226	0.00181	CcSEcCtD
Glyburide—Decreased appetite—Ifosfamide—testicular cancer	0.000225	0.00181	CcSEcCtD
Glyburide—Headache—Vinblastine—testicular cancer	0.000224	0.0018	CcSEcCtD
Glyburide—Leukopenia—Etoposide—testicular cancer	0.000224	0.0018	CcSEcCtD
Glyburide—Purpura—Doxorubicin—testicular cancer	0.000224	0.0018	CcSEcCtD
Glyburide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000223	0.00179	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—testicular cancer	0.000223	0.00179	CcSEcCtD
Glyburide—Oedema—Cisplatin—testicular cancer	0.000223	0.00179	CcSEcCtD
Glyburide—Hypersensitivity—Bleomycin—testicular cancer	0.000223	0.00179	CcSEcCtD
Glyburide—ABCB1—female gonad—testicular cancer	0.000222	0.00254	CbGeAlD
Glyburide—Hypoglycaemia—Doxorubicin—testicular cancer	0.000221	0.00177	CcSEcCtD
Glyburide—Nervous system disorder—Cisplatin—testicular cancer	0.000219	0.00176	CcSEcCtD
Glyburide—Thrombocytopenia—Cisplatin—testicular cancer	0.000218	0.00175	CcSEcCtD
Glyburide—Asthenia—Bleomycin—testicular cancer	0.000217	0.00174	CcSEcCtD
Glyburide—Convulsion—Etoposide—testicular cancer	0.000217	0.00174	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—testicular cancer	0.000216	0.00174	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—testicular cancer	0.000216	0.00173	CcSEcCtD
Glyburide—Hyperhidrosis—Cisplatin—testicular cancer	0.000216	0.00173	CcSEcCtD
Glyburide—Pruritus—Bleomycin—testicular cancer	0.000214	0.00172	CcSEcCtD
Glyburide—Feeling abnormal—Ifosfamide—testicular cancer	0.000213	0.00171	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—testicular cancer	0.000213	0.00171	CcSEcCtD
Glyburide—Nausea—Vinblastine—testicular cancer	0.000213	0.00171	CcSEcCtD
Glyburide—Anorexia—Cisplatin—testicular cancer	0.000213	0.00171	CcSEcCtD
Glyburide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000211	0.0017	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—testicular cancer	0.000211	0.00169	CcSEcCtD
Glyburide—Hypotension—Cisplatin—testicular cancer	0.000208	0.00167	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—testicular cancer	0.000208	0.00167	CcSEcCtD
Glyburide—Confusional state—Etoposide—testicular cancer	0.000206	0.00165	CcSEcCtD
Glyburide—Urticaria—Ifosfamide—testicular cancer	0.000205	0.00165	CcSEcCtD
Glyburide—Abdominal pain—Ifosfamide—testicular cancer	0.000204	0.00164	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—testicular cancer	0.000204	0.00164	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000203	0.00163	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—testicular cancer	0.000203	0.00163	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—testicular cancer	0.000202	0.00163	CcSEcCtD
Glyburide—Paraesthesia—Cisplatin—testicular cancer	0.0002	0.00161	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—testicular cancer	0.0002	0.00161	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—testicular cancer	0.000199	0.0016	CcSEcCtD
Glyburide—Dyspnoea—Cisplatin—testicular cancer	0.000199	0.0016	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—testicular cancer	0.000197	0.00159	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—testicular cancer	0.000197	0.00159	CcSEcCtD
Glyburide—ABCB1—testis—testicular cancer	0.000197	0.00226	CbGeAlD
Glyburide—Photosensitivity reaction—Methotrexate—testicular cancer	0.000196	0.00158	CcSEcCtD
Glyburide—Anorexia—Etoposide—testicular cancer	0.000195	0.00156	CcSEcCtD
Glyburide—Decreased appetite—Cisplatin—testicular cancer	0.000194	0.00156	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—testicular cancer	0.000193	0.00155	CcSEcCtD
Glyburide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000192	0.00155	CcSEcCtD
Glyburide—Vomiting—Bleomycin—testicular cancer	0.000192	0.00155	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—testicular cancer	0.000191	0.00154	CcSEcCtD
Glyburide—Hypotension—Etoposide—testicular cancer	0.000191	0.00153	CcSEcCtD
Glyburide—Rash—Bleomycin—testicular cancer	0.000191	0.00153	CcSEcCtD
Glyburide—Dermatitis—Bleomycin—testicular cancer	0.000191	0.00153	CcSEcCtD
Glyburide—Hypersensitivity—Ifosfamide—testicular cancer	0.000191	0.00153	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—testicular cancer	0.000188	0.00151	CcSEcCtD
Glyburide—Asthenia—Ifosfamide—testicular cancer	0.000186	0.00149	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—testicular cancer	0.000184	0.00148	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—testicular cancer	0.000184	0.00148	CcSEcCtD
Glyburide—Feeling abnormal—Cisplatin—testicular cancer	0.000184	0.00148	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—testicular cancer	0.000183	0.00147	CcSEcCtD
Glyburide—Pruritus—Ifosfamide—testicular cancer	0.000183	0.00147	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—testicular cancer	0.000183	0.00147	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—testicular cancer	0.000182	0.00146	CcSEcCtD
Glyburide—Nausea—Bleomycin—testicular cancer	0.00018	0.00144	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—testicular cancer	0.000179	0.00144	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—testicular cancer	0.000179	0.00144	CcSEcCtD
Glyburide—Rash—Dactinomycin—testicular cancer	0.000178	0.00143	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—testicular cancer	0.000178	0.00143	CcSEcCtD
Glyburide—Diarrhoea—Ifosfamide—testicular cancer	0.000177	0.00142	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—testicular cancer	0.000177	0.00142	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000176	0.00142	CcSEcCtD
Glyburide—Jaundice—Epirubicin—testicular cancer	0.000175	0.00141	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—testicular cancer	0.000172	0.00138	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00017	0.00137	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—testicular cancer	0.000168	0.00135	CcSEcCtD
Glyburide—Nausea—Dactinomycin—testicular cancer	0.000168	0.00135	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—testicular cancer	0.000168	0.00135	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—testicular cancer	0.000167	0.00134	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—testicular cancer	0.000166	0.00133	CcSEcCtD
Glyburide—Vomiting—Ifosfamide—testicular cancer	0.000164	0.00132	CcSEcCtD
Glyburide—Hypersensitivity—Cisplatin—testicular cancer	0.000164	0.00132	CcSEcCtD
Glyburide—Rash—Ifosfamide—testicular cancer	0.000163	0.00131	CcSEcCtD
Glyburide—Dermatitis—Ifosfamide—testicular cancer	0.000163	0.00131	CcSEcCtD
Glyburide—Urticaria—Etoposide—testicular cancer	0.000162	0.0013	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—testicular cancer	0.000162	0.0013	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—testicular cancer	0.000161	0.0013	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—testicular cancer	0.000161	0.00129	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—testicular cancer	0.000161	0.00129	CcSEcCtD
Glyburide—Asthenia—Cisplatin—testicular cancer	0.00016	0.00129	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—testicular cancer	0.000155	0.00125	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—testicular cancer	0.000155	0.00125	CcSEcCtD
Glyburide—Nausea—Ifosfamide—testicular cancer	0.000154	0.00123	CcSEcCtD
Glyburide—Diarrhoea—Cisplatin—testicular cancer	0.000153	0.00123	CcSEcCtD
Glyburide—Alopecia—Methotrexate—testicular cancer	0.000152	0.00122	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—testicular cancer	0.000151	0.00121	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—testicular cancer	0.00015	0.00121	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—testicular cancer	0.00015	0.0012	CcSEcCtD
Glyburide—Erythema—Methotrexate—testicular cancer	0.00015	0.0012	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—testicular cancer	0.000149	0.0012	CcSEcCtD
Glyburide—Asthenia—Etoposide—testicular cancer	0.000147	0.00118	CcSEcCtD
Glyburide—Pruritus—Etoposide—testicular cancer	0.000145	0.00116	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—testicular cancer	0.000144	0.00115	CcSEcCtD
Glyburide—ABCB1—lymph node—testicular cancer	0.000143	0.00164	CbGeAlD
Glyburide—Alopecia—Epirubicin—testicular cancer	0.000142	0.00114	CcSEcCtD
Glyburide—Vomiting—Cisplatin—testicular cancer	0.000142	0.00114	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—testicular cancer	0.000141	0.00114	CcSEcCtD
Glyburide—Rash—Cisplatin—testicular cancer	0.000141	0.00113	CcSEcCtD
Glyburide—Dermatitis—Cisplatin—testicular cancer	0.00014	0.00113	CcSEcCtD
Glyburide—Erythema—Epirubicin—testicular cancer	0.00014	0.00113	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—testicular cancer	0.00014	0.00113	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—testicular cancer	0.00014	0.00112	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—testicular cancer	0.000139	0.00112	CcSEcCtD
Glyburide—Anaemia—Methotrexate—testicular cancer	0.000139	0.00111	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—testicular cancer	0.000134	0.00108	CcSEcCtD
Glyburide—Nausea—Cisplatin—testicular cancer	0.000132	0.00106	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—testicular cancer	0.000132	0.00106	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—testicular cancer	0.000132	0.00106	CcSEcCtD
Glyburide—Convulsion—Methotrexate—testicular cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Vomiting—Etoposide—testicular cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—testicular cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Erythema—Doxorubicin—testicular cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Anaemia—Epirubicin—testicular cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Rash—Etoposide—testicular cancer	0.000129	0.00103	CcSEcCtD
Glyburide—Dermatitis—Etoposide—testicular cancer	0.000129	0.00103	CcSEcCtD
Glyburide—Headache—Etoposide—testicular cancer	0.000128	0.00103	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—testicular cancer	0.000128	0.00103	CcSEcCtD
Glyburide—Myalgia—Methotrexate—testicular cancer	0.000128	0.00103	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—testicular cancer	0.000126	0.00101	CcSEcCtD
Glyburide—Confusional state—Methotrexate—testicular cancer	0.000123	0.000991	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—testicular cancer	0.000122	0.000983	CcSEcCtD
Glyburide—Convulsion—Epirubicin—testicular cancer	0.000122	0.000977	CcSEcCtD
Glyburide—Nausea—Etoposide—testicular cancer	0.000121	0.000975	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—testicular cancer	0.00012	0.000964	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—testicular cancer	0.00012	0.000964	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—testicular cancer	0.00012	0.000962	CcSEcCtD
Glyburide—Myalgia—Epirubicin—testicular cancer	0.000119	0.00096	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—testicular cancer	0.000119	0.00096	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—testicular cancer	0.000118	0.00095	CcSEcCtD
Glyburide—Anorexia—Methotrexate—testicular cancer	0.000117	0.000937	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—testicular cancer	0.000116	0.000933	CcSEcCtD
Glyburide—Confusional state—Epirubicin—testicular cancer	0.000115	0.000927	CcSEcCtD
Glyburide—Oedema—Epirubicin—testicular cancer	0.000114	0.00092	CcSEcCtD
Glyburide—Hypotension—Methotrexate—testicular cancer	0.000114	0.000918	CcSEcCtD
Glyburide—Shock—Epirubicin—testicular cancer	0.000113	0.000905	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—testicular cancer	0.000112	0.000904	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—testicular cancer	0.000112	0.000902	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—testicular cancer	0.000112	0.000901	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000111	0.000896	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—testicular cancer	0.000111	0.000889	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—testicular cancer	0.000111	0.000888	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—testicular cancer	0.000111	0.000888	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—testicular cancer	0.00011	0.000883	CcSEcCtD
Glyburide—Anorexia—Epirubicin—testicular cancer	0.000109	0.000877	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—testicular cancer	0.000109	0.000876	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—testicular cancer	0.000108	0.000865	CcSEcCtD
Glyburide—Hypotension—Epirubicin—testicular cancer	0.000107	0.00086	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—testicular cancer	0.000107	0.000858	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—testicular cancer	0.000106	0.000854	CcSEcCtD
Glyburide—Oedema—Doxorubicin—testicular cancer	0.000106	0.000851	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000106	0.000849	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000104	0.000838	CcSEcCtD
Glyburide—Shock—Doxorubicin—testicular cancer	0.000104	0.000837	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—testicular cancer	0.000104	0.000835	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000104	0.000833	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—testicular cancer	0.000103	0.000826	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000102	0.000823	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—testicular cancer	0.000102	0.00082	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—testicular cancer	0.000101	0.000811	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—testicular cancer	0.000101	0.00081	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—testicular cancer	0.000101	0.00081	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—testicular cancer	0.0001	0.000804	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—testicular cancer	9.95e-05	0.0008	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—testicular cancer	9.9e-05	0.000795	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—testicular cancer	9.88e-05	0.000794	CcSEcCtD
Glyburide—Urticaria—Methotrexate—testicular cancer	9.72e-05	0.000781	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—testicular cancer	9.67e-05	0.000777	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.65e-05	0.000775	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—testicular cancer	9.51e-05	0.000764	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—testicular cancer	9.44e-05	0.000759	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—testicular cancer	9.43e-05	0.000758	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—testicular cancer	9.36e-05	0.000752	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—testicular cancer	9.33e-05	0.000749	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—testicular cancer	9.21e-05	0.00074	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—testicular cancer	9.15e-05	0.000735	CcSEcCtD
Glyburide—Urticaria—Epirubicin—testicular cancer	9.1e-05	0.000731	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—testicular cancer	9.05e-05	0.000727	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—testicular cancer	9.01e-05	0.000724	CcSEcCtD
Glyburide—Asthenia—Methotrexate—testicular cancer	8.78e-05	0.000705	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—testicular cancer	8.73e-05	0.000701	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—testicular cancer	8.66e-05	0.000696	CcSEcCtD
Glyburide—Pruritus—Methotrexate—testicular cancer	8.66e-05	0.000695	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—testicular cancer	8.44e-05	0.000678	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—testicular cancer	8.42e-05	0.000676	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—testicular cancer	8.37e-05	0.000673	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—testicular cancer	8.37e-05	0.000673	CcSEcCtD
Glyburide—Asthenia—Epirubicin—testicular cancer	8.21e-05	0.00066	CcSEcCtD
Glyburide—Pruritus—Epirubicin—testicular cancer	8.1e-05	0.000651	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—testicular cancer	7.83e-05	0.000629	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—testicular cancer	7.81e-05	0.000627	CcSEcCtD
Glyburide—Vomiting—Methotrexate—testicular cancer	7.78e-05	0.000625	CcSEcCtD
Glyburide—Rash—Methotrexate—testicular cancer	7.71e-05	0.00062	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—testicular cancer	7.71e-05	0.000619	CcSEcCtD
Glyburide—Headache—Methotrexate—testicular cancer	7.66e-05	0.000616	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—testicular cancer	7.6e-05	0.000611	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—testicular cancer	7.49e-05	0.000602	CcSEcCtD
Glyburide—Vomiting—Epirubicin—testicular cancer	7.28e-05	0.000585	CcSEcCtD
Glyburide—Nausea—Methotrexate—testicular cancer	7.27e-05	0.000584	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—testicular cancer	7.25e-05	0.000582	CcSEcCtD
Glyburide—Rash—Epirubicin—testicular cancer	7.22e-05	0.00058	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—testicular cancer	7.21e-05	0.000579	CcSEcCtD
Glyburide—Headache—Epirubicin—testicular cancer	7.17e-05	0.000576	CcSEcCtD
Glyburide—Nausea—Epirubicin—testicular cancer	6.8e-05	0.000546	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—testicular cancer	6.74e-05	0.000541	CcSEcCtD
Glyburide—Rash—Doxorubicin—testicular cancer	6.68e-05	0.000537	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—testicular cancer	6.67e-05	0.000536	CcSEcCtD
Glyburide—Headache—Doxorubicin—testicular cancer	6.64e-05	0.000533	CcSEcCtD
Glyburide—Nausea—Doxorubicin—testicular cancer	6.29e-05	0.000506	CcSEcCtD
